Clinical research organizations (CROs) assist in the successful implementation of clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations that benefit trial sponsors. For example, on average, CROs take 30% lesser time than in-house activity to conduct and complete clinical trials. With the rising number of CROs leading to high competition, a few of these businesses offer specialized imaging services, thus emerging as imaging CROs (iCROs). A few examples of iCROs include Keosys Medical Imaging and Medica Group PLC. CROs offer key knowledge insights in areas such as site qualification for imaging, acquisition of standardized images, and determination of read designs and criteria, thereby contributing to the growth of the overall North America clinical trial imaging market.
The North America clinical trial imaging market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for clinical trial imaging. The market growth in the region is attributed to the US emerging as a leading clinical research destination and a growing number of innovative product launches by companies for applications in clinical trials. The US has emerged as a leading clinical research destination. Approximately half of the total clinical trials conducted globally are conducted in the US. Additionally, most pharma research companies prefer to perform clinical trials in the US owing to established medical infrastructure, fast approval timelines, a favorable regulatory framework, and accepted clinical trial-generated data.
The North America clinical trial imaging market is segmented on the basis of modality, offering, end user, and country.
Based on modality, the North America clinical trial imaging market is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-ray, echocardiography, and others. The tomography segment registered the largest market share in 2023.
Based on offering, the North America clinical trial imaging market is segmented into operational imaging services, imaging software, read analysis services, trial design and consulting services, and others. The operational imaging services segment held the largest market share in 2023.
Based on end user, the North America clinical trial imaging market is segmented into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutes, and others. The contract research organizations (CROs) segment held the largest market share in 2023.
Based on country, the market is segmented into US, Canada, and Mexico. The US dominated the market share in 2023.
BioTelemetry Inc, Calyx Inc, eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, Medpace Holdings Inc, VIDA Diagnostics Inc, and WCG Clinical Inc are the leading companies operating in the North America clinical trial imaging market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 704.94 Million |
| Market Size by 2028 | US$ 1,025.61 Million |
| CAGR (2023 - 2028) | 7.8% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By Modality
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
1. BioTelemetry Inc
2. Calyx Inc
3. eResearch Technology Inc
4. ICON PLC
5. IXICO plc
6. Medical Metrics Inc
7. Medpace Holdings Inc
8. VIDA Diagnostics Inc
9. WCG Clinical Inc
The North America Clinical Trial Imaging Market is valued at US$ 704.94 Million in 2023, it is projected to reach US$ 1,025.61 Million by 2028.
As per our report North America Clinical Trial Imaging Market, the market size is valued at US$ 704.94 Million in 2023, projecting it to reach US$ 1,025.61 Million by 2028. This translates to a CAGR of approximately 7.8% during the forecast period.
The North America Clinical Trial Imaging Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Clinical Trial Imaging Market report:
The North America Clinical Trial Imaging Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Clinical Trial Imaging Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Clinical Trial Imaging Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Clinical Trial Imaging Market
